Reducing occupational stress with a B-vitamin focussed intervention: a randomized clinical trial: study protocol

Nutrition Journal

Luke A Downey¹  Chris Oliver²  Stephen Myers²  Clare Billings³  Grace McPhee³  Justine Lomas³  Tamara Simpson³  Con Stough³ 

[1] Department of Psychology, Swansea University, Swansea, Wales, UK;NatMed Research Unit, Southern Cross University, Lismore, NSW, Australia;Centre for Human Psychopharmacology, Swinburne University, PO Box 218, HawthornVictoria, Melbourne, Australia

关键词: MRS;    fMRI;    MRI;    Work-related stress;    Occupational stress;    Homocysteine;    Genetics;    Cognition;    Stress;    B vitamins;   

Others  :  1132385
DOI  :  10.1186/1475-2891-13-122

 received in 2014-07-30, accepted in 2014-12-12,  发布年份 2014

【 摘 要 】

Background

Workplace stress in Australia and other western countries has been steadily increasing over the past decade. It can be observed not only in terms of increased compensation claims but also costs due to absenteeism, loss of productivity at work and reduced psychological and physiological health and well-being. Given the cost and pervasive effects of stress in the modern workforce, time efficient and cost-effective interventions capable of reducing occupational stress (or strain) and burnout are urgently required for the improved well-being of stressed employees. One intervention gaining scientific traction is supplementation with nutritional interventions, particularly the B group vitamins.

Methods

This study was developed to examine the effects of B group vitamins on workplace stress and mood variables with a sample of full-time employed older adults who subjectively report feeling stressed. The study is a randomized, double-blind, placebo-controlled, parallel-groups clinical trial where 200 (N = 100/group) participants will be randomized to receive Blackmores® Executive B Stress Formula or placebo daily for a period of 6 months. Participants will be tested at baseline and 6 months post-randomization on workplace stress, cognitive, personality and mood measures, cardiovascular (brachial and aortic systolic and diastolic blood pressures as well as arterial stiffness), biochemical (assays to measure inflammation and safety) as well as genetic assessments (to assess stress processing) and neuroimaging measures (to investigate in vivo mechanisms of action of B vitamins). In addition to this pre- and post- supplementation testing, participants will also complete a battery of self-report questionnaires online to assess their stress and mood once a month for the duration of the study. The primary aim of the study is to investigate the effects of B vitamin supplementation on work related stress. The secondary aims are to explore the mechanisms underpinning any changes in mood or workplace stress due to the B vitamin intervention by examining relationships between cognitive, biological, neuroimaging and cardiovascular variables over 6 months. A subset of 40 participants (N = 20/group) will undergo neuroimaging at baseline and at 6 months using functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) in order to further explore in vivo mechanisms of action of B vitamins.

Trial registration

Australia and New Zealand Clinical Trials Register (ANZCTR):ACTRN12613000294752

【 授权许可】

   
2014 Stough et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Guthrie R, Ciccarelli M, Babic A: Work-related stress in Australia: The effects of legislative interventions and the cost of treatment. Int J Law Psychiatry 2010, 33:101-115.
• [2]The cost of workplace stress in Australia http://www.medibank.com.au/client/documents/pdfs/the-cost-of-workplace-stress.pdf webcite
• [3]Work-related stress: scientific evidence-base of risk factors, prevention and costs http://www.who.int/occupational_health/topics/brunpres0307.pdf?ua=1 webcite
• [4]The National Institute for Occupational Safety and Health (NIOSH): Stress at work. http://www.cdc.gov/niosh/docs/99-101/ webcite
• [5]Bourre JM: Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging 2006, 10:377-385.
• [6]Ames BN: Oxygen radicals and degenerative diseases. Science 1983, 221:1256-1264.
• [7]Sohal RS, Orr WC: The redox stress hypothesis of aging. Free Radic Biol Med 2012, 52:539-555.
• [8]Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA: Neurobehavioural aspects of antioxidants in aging. Int J Dev Neurosci 2000, 18:367-381.
• [9]Mariani E, Polidori MC, Cherubini A, Mecocci P: Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B 2005, 827:65-75.
• [10]Huskisson E, Maggini S, Ruf M: The Influence of Micronutrients on Cognitive Function and Performance. J Int Med Res 2007, 35:1-19.
• [11]Selhub J: Public health significance of elevated homocysteine. Food Nutr Bull 2008, 29:S116-S125.
• [12]Sachdev PS: Homocysteine and brain atrophy. Prog Neuro-Psychopharmacol Biol Psychiatry 2005, 29:1152-1161.
• [13]Mattson MP, Shea TB: Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003, 26:137-146.
• [14]Miller AL: The methionine-homocysteine cylce and its effects on cognitive diseases. Altern Med Rev 2003, 8:7-19.
• [15]Kruman II, Culmsee C, Chan SL, Guo Z, Penix L, Mattson MP: Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000, 20:6920-6926.
• [16]Ford AH, Flicker L, Urvashnee S, Hirani V, Almeida OP: Homocysteine, depression and cognitive function in older adults. J Affect Disord 2013, 151:646-651.
• [17]Stoney CM: Plasma homocysteine levels increase in women during psychological stress. Life Sci 1999, 64:2359-2365.
• [18]Blasko I, Hinterberger M, Kemmler G, Jungwirth S, Krampla W, Leitha T, Heinz Tragl K, Fischer P: Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort. J Nutr Health Aging 2012, 16:687-694.
• [19]Tangney CC, Aggarwal NT, Li H, Wilson RS, DeCarli C, Evans DA, Morris MC: Vitamin B12, cognition, and brain MRI measures. A cross-sectional Examination. Neruology 2011, 77:1276-1282.
• [20]Benton D: To establish the parameters of optimal nutrition do we need to consider psychological in addition to physiological parameters? Mol Nutr Food Res 2013, 57:6-19.
• [21]Long SJ, Benton D: Effects of vitamin and mineral supplementation on stress, mild psychiatric symptoms, and mood in nonclinical samples: A meta-analysis. Psychosom Med 2013, 75:144-153.
• [22]Leka S, Griffiths A, Cox T: Work Organization and Stress: Systematic Problem Approaches for Employers, Managers and Trade Union Representatives. Work Organ Stress 2003.
• [23]Stough C, Scholey A, Lloyd J, Spong J, Myers S, Downey LA: The effect of 90 day administration of a high dose vitamin B-complex on work stress. Human Psychopharmacol 2011, 26:470-476.
• [24]Carroll D, Ring C, Suter M, Willemsen G: The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: A double-blind placebo-controlled trial. Psychopharmacology 2000, 150:220-225.
• [25]Schlebusch L, Bosch BA, Polglase G, Kleinschmidt I, Pillay BJ, Cassimjee MH: A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. S Afr Med J 2000, 90:1216-1223.
• [26]Kennedy DO, Veasey R, Watson A, Dodd F, Jones E, Maggini S, Haskell CF: Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males. Psychopharmacology 2010, 211:55-68.
• [27]Chamorro-Premuzic T, Ahmetoglu G, Furnham A: Little more than personality: Dispositional determinants of test anxiety (the Big Five, core self-evaluations, and self-assessed intelligence). Learn Individ Differ 2008, 18:258-263.
• [28]Durga J, van Boxtel MP, Schouten EG, Lok FJ, Jolles J, Katan MB, Verhoef P: Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a ranomised, double blind, controlled trial. Lancet 2007, 369:208-216.
• [29]Bryan J: The role of nutritional factors in cognitive ageing. In The Ageing Brain. Edited by Lisse SP. The Netherlands: Swets & Zeitlinger B.V; 2003:205-222.
• [30]Lildballe DL, Fedosov S, Sherlinker P, Hin H, Clarke R, Nexo E: Association of cognitive impairment with combinations of vitamin B12 related parameters. Clin Chem 2011, 57:1436-1443.
• [31]Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D: Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012, 24:541-556.
• [32]Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H: Homocysteine-lowering by B vitamins slows the rate of accelarated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE 2010, 5:1-10.
• [33]de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD: Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry 2012, 27:592-600.
• [34]Pipingas A, Camfield DA, Stough C, Cox KHM, Fogg E, Tiplady B, White DJ, Sali A, Wetherell MA, Scholey AB: The effects of multivitamin supplementation on mood and general well-being in healthy young adults. A laboratory and at-home mobile phone assessment. Appetite 2013, 69:123-136.
• [35]Rosenberg IH, Miller JW: Nutritional factos in physical and cognitive functions of elderly people. Am J Clin Nutr 1992, 55:1237S-1243S.
• [36]Smithels RW, Sheppard S, Schorah CJ: Vitamin deficiencies and neural tube defects. Arch Dis Child 1976, 51:944-950.
• [37]Gröber U, Kisters K, Schmidt J: Neuroenhancement with vitamin B12 - Underestimated neurological significance. Nutrients 2013, 5:5031-5045.
• [38]Obeid R, Herrmann W: Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006, 5801:2994-3005.
• [39]Parletta N, Milte CM, Meyer BJ: Nutritional modulation of cognitive function and mental health. J Nutr Biochem 2013, 24:725-743.
• [40]Tchantchou F, Graves M, Falcone D, Shea TB: S-Adensosylmethionine mediates glutathione efficacy by increasing glutathione s-transferase activity: implications for s-adenosyl methionine as a neuroprotective dietary supplment. J Alzheimers Dis 2008, 14:323-328.
• [41]Papakostas GI, Alpert JE, Fava M: S-adenosly-methionine in depression: A comprehensive review of the literature. Curr Psychiatry Rep 2003, 5:460-466.
• [42]Williams AL, Girard C, Jui D, Savina A, Katz DL: S-adenosylmethionine (SAMe) as treatment for depression: A systematic review. Clin Investig Med 2005, 28:132-139.
• [43]Calvaresi E, Bryan J: B vitamins, cognition and aging: A review. J Gerontol Psychol Sci 2001, 56B:P327-P339.
• [44]de Koning LAB, Werstuck GH, Zhou J, Austin RC: Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin Biochem 2003, 36:431-441.
• [45]Kang MG, Koh SB, Cha BS, Park JK, Baik SK, Chang SJ: Job stress and cardiovascular risk factors in male workers. Prev Med 2005, 40:583-588.
• [46]Spielberger CD, Gorsuch RL, Lushene RE: Manual for the State-Trait Anxiety Inventory. Palo Alto California: Consulting Psychologists Press; 1970.
• [47]Wechsler D: Wechsler abbreviated scale of intelligence. New York, NY: Psychological Corporation: Harcourt Brace & Company; 1999.
• [48]Osipow SH, Spokane AR: Occupational Stress Inventory-Revised. FL: Odessa; 1998. Psychological. 1–15
• [49]Pipingas A, Harris E, Tournier E, King R, Kras M, Stough CK: Assessing the efficacy of neutraceutical interventions on cognitive functioning in the elderly. Curr Top Nutraceutical Res 2010, 8:79-87.
• [50]Harris E, Kirk J, Rowsell R, Vitetta L, Sali A, Scholey AB, Pipingas A: The effect of multivitamin supplementation on mood and stress in healthy older men. Human Psychopharmacol 2011, 26:560-567.
• [51]Macpherson H, Ellis KA, Sali A, Pipingas A: Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement. Psychopharmacology 2012, 220:351-365.
• [52]Cohen ST, Kamarck T, Mermelstein R: A global measure of perceived stress. J Health Soc Behav 1983, 24:385-396.
• [53]Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
• [54]McNair DM, Lorr M, Droppleman LM: Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1970.
• [55]Goldberg DP: Manual of the General Health Questionnaire. Windsor, UK: NFER Publishing Company; 1978.
• [56]Costa PT, McCrae RR: The revised NEO personality inventory (NEO-PI-R). In The SAGE handbook of personality theory and assessment: Volume 2 - Personality Measurement and testing. Edited by Boyle G, Matthews G, Saklofske D. London: SAGE Publications Ltd; 2008.
• [57]Kivimäki M, Virtanen M, Elovainio M, Kouvonen A, Väänänen A, Vahtera J: Work stress in the etiology of coronary heart disease - A meta-analysis. Scand J Work Environ Health 2006, 32:431-442.
• [58]Tsao CW, Seshadri S, Beiser AS, Westwood AJ, DeCarli C, Au R, Himali JJ, Hamburg NM, Vita JA, Levy D, Larson MG, Benjamin EJ, Wolf PA, Vasan RS, Mitchell GF: Relations of arterial stiffness and endothelial function to brain aging in the community. Neruology 2013, 81:984-991.
• [59]Pase MP, Herbert A, Grima NA, Pipingas A, O’Rourke MF: Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta-analysis. Intern Med J 2012, 42:808-815.
• [60]Boutouyrie P, Vermeersch SJ: Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 2010, 31:2338-2350.
• [61]Laurent S, Cockroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachoplouos C, Wilkinson I, Struijker-Boudier H: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
• [62]Bevilacqua L, Goldman D: Genetics of emotion. Trends Cogn Sci 2011, 15:401-408.
• [63]Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F: Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000, 47:305-313.
• [64]Berger GE, Wood SJ, Wellard RM, Proffitt TM, McConchie M, Amminger GP, Jackson GD, Velakoulis D, Pantelis C, McGorry PD: Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study. Neuropsychopharmacology 2008, 33:2467-2473.
• [65]Kantarci K, Jack CR, Xu YC, Campeau NG, O’Brien PC, Smith GE, Ivnik RJ, Boeve BF, Kokmen E, Tangalos EG, Petersen RC: Regional metabolic patterns in mild cognitive impariment and Alzheimer’s disease: A 1H MRS study. Neurology 2000, 55:210-217.
• [66]Mandal PK, Tripathi M, Sugunan S: Brian oxidative stress: Detection and mapping of anti-oxidant marker ‘Glutathione’ in different brain regions of healthy male/female, MCI and Alzheimer’s patients using non-invasive magnetic resonance spectroscopy. Biochem Biophys Res Commun 2012, 417:43-48.
• [67]Barch DM, Burgess GC, Harms MP, Petersen SE, Schlaggar BL, Corbetta M, Glasser MF, Curtiss S, Dixit S, Feldt C, Nolan D, Bryant E, Hartley T, Footer O, Bjork JM, Poldrack R, Smith S, Johansen-Berg H, Snyder AZ, Van Essen DC: Function in the human connectome: Task-fMRI and individual differences in behavior. Neuroimage 2013, 80:169-189.
• [68]Cabeza R, Nyberg L: Imaging cognition II: An Empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000, 12:1-47.
• [69]Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Clifford RJ: 1H magnetic resonance spectrsoscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer’s disease. J Int Neuropsychol Soc 2002, 8:934-942.
• [70]Timoshanko A, Desmond P, Camfield DA, Downey LA, Stough C: A magnetic resonance spectroscopy (1H MRS) investigation into brain metabolite correlates of ability emotional intelligence. Personal Individ Differ 2014, 65:69-74.